tiprankstipranks
Advertisement
Advertisement

TSE:TLT Stock Latest News

Company AnnouncementsTheralase Posts 100% Preclinical Response in Muscle Invasive Bladder Cancer Study
19h ago
PremiumCompany Announcements
Theralase Raises C$2.66 Million to Advance Bladder Cancer Drug Programs
3d ago
PremiumCompany Announcements
Theralase Uncovers New Antiviral Mechanism for Ruvidar Against Herpes Virus
28d ago
PremiumCompany Announcements
Theralase Raises C$1.1 Million to Advance Bladder Cancer Trial
1M ago
PremiumCompany Announcements
Theralase’s Rutherrin Boosts Radiation Efficacy in Muscle Invasive Bladder Cancer Models
1M ago
PremiumCompany AnnouncementsTheralase Preclinical Data Backs Ruvidar–Interferon Combo for Bladder Cancer
1M ago
Premium
Company Announcements
Theralase Preclinical Data Backs Ruvidar–Interferon Combo in Bladder Cancer
1M ago
Premium
Company Announcements
Theralase Bladder Cancer Data Heads to Major Urology Congress as Regulatory Plans Advance
2M ago
PremiumCompany Announcements
Theralase Bladder Cancer Data to Headline 2026 European Urology Congress
2M ago
PremiumCompany Announcements
Theralase Bladder Cancer Data to Debut at 2026 European Urology Congress
2M ago
PremiumCompany Announcements
Theralase Bladder Cancer Data Heads to Key Urology Conference as Regulatory Filings Near
2M ago
PremiumCompany Announcements
Theralase’s Bladder Cancer Therapy Exceeds Key Benchmarks in Phase II Trial
2M ago
PremiumCompany AnnouncementsTheralase Hits Key Enrollment Milestone in Phase II Bladder Cancer Trial
2M ago
Theralase and Ferring Launch Combination Trial for BCG-Unresponsive Bladder Cancer
Premium
Company Announcements
Theralase and Ferring Launch Combination Trial for BCG-Unresponsive Bladder Cancer
3M ago
Theralase Raises C$1.3 Million to Advance Bladder Cancer Trial
Premium
Company Announcements
Theralase Raises C$1.3 Million to Advance Bladder Cancer Trial
4M ago
Theralase Launches Private Placement to Fund Cancer Research
PremiumCompany Announcements
Theralase Launches Private Placement to Fund Cancer Research
4M ago
Theralase Technologies Secures Funding to Advance Cancer Treatment Study
PremiumCompany Announcements
Theralase Technologies Secures Funding to Advance Cancer Treatment Study
5M ago
Theralase Reports Promising Cancer Study Results Amid Financial Challenges
PremiumCompany Announcements
Theralase Reports Promising Cancer Study Results Amid Financial Challenges
5M ago
Theralase Technologies Reports Q3 2025 Financials and Clinical Progress
PremiumCompany Announcements
Theralase Technologies Reports Q3 2025 Financials and Clinical Progress
5M ago
Theralase’s Rutherrin® Shows Promise in Preclinical Cancer Treatment
PremiumCompany AnnouncementsTheralase’s Rutherrin® Shows Promise in Preclinical Cancer Treatment
5M ago
Theralase’s Ruvidar® Shows Promise Against Herpes Simplex Virus
Premium
Company Announcements
Theralase’s Ruvidar® Shows Promise Against Herpes Simplex Virus
7M ago
Theralase Extends Warrant Expiry to Bolster Market Position
Premium
Company Announcements
Theralase Extends Warrant Expiry to Bolster Market Position
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >